RecalledThisWeek Search
Medium risk Drugs & MedicationsClass II

Methohexital Sodium Injection Recall

Methohexital Sodium for Injection, USP 500 mg Multiple Dose Vial, Rx Only, Manufactured by: OneSource Specialty, Pharma Limited, Bengaluru -

Updated June 7, 2026

Methohexital Sodium for Injection 500 mg multiple dose vials made by OneSource Specialty Pharma have failed quality tests for impurities and degradation. Healthcare providers should not use affected vials.

Is the ONESOURCE SPECIALTY PHARMA LIMITED recalled? Yes. This product was recalled by FDA on June 7, 2026. Details below.

What is recalled

Methohexital Sodium for Injection, USP 500 mg multiple dose vial, NDC 23155-893-31, manufactured by OneSource Specialty Pharma Limited, Bengaluru, India and distributed by Avet Pharmaceuticals Inc., East Brunswick, NJ.

Am I affected

You're affected if you work in a healthcare setting and have received or are using Methohexital Sodium for Injection 500 mg vials with NDC 23155-893-31. Check the NDC number on the vial label.

What to do right now

If you have this medication in your facility, stop using it immediately. Contact your pharmacy supplier or Avet Pharmaceuticals Inc. to return the vials and obtain tested replacement stock.

The hazard

Failed Impurities/Degradation Specifications

Brands affected

ONESOURCE SPECIALTY PHARMA LIMITED
Source
FDA
Category
Drugs & Medications
Recall ID
fda-D-0662-2026
Classification
Class II
Recalled
June 7, 2026
Read the official notice

Get free recall alerts

New Drugs & Medications recalls, the moment they post.

Free forever. Unsubscribe anytime. We never sell your data.

More Drugs & Medications recalls